Caring Brands (CABR) Income towards Parent Company (2024 - 2026)
Caring Brands' (CABR) quarterly Income towards Parent Company came in at -$3.4 million in Q1 2026, down 537.2% year-on-year from $786690.0 in Q1 2025, and up 7.94% quarter-over-quarter from -$3.7 million in Q4 2025.
Caring Brands (CABR) Income towards Parent Company (2024 - 2026) Analysis & Trends
Caring Brands' Income towards Parent Company history runs 3 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 537.2% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$9.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$7.4 million, down 2740.12% from the prior year.
- Income towards Parent Company climbed to -$3.4 million in Q1 2026 per CABR's latest filing, from -$3.7 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$428906.0 in Q3 2024 and bottomed at -$3.7 million in Q4 2025.
- The 3-year median for Income towards Parent Company is -$1.3 million (2024), against an average of -$1.8 million.
- Across the five-year window, Income towards Parent Company slumped 283.88% in 2025 and sank 537.2% in 2026, its largest moves.
- Year by year, Income towards Parent Company stood at -$862791.0 in 2024, then slumped by 333.02% to -$3.7 million in 2025, then increased by 7.94% to -$3.4 million in 2026.
- Per Business Quant, the three latest CABR Income towards Parent Company figures stand at -$3.4 million (Q1 2026), -$3.7 million (Q4 2025), and -$1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | Caring Brands | 20.66 Mn | 18.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.44 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -539,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |